Laurie E Gaspar Selected Research

Combined Modality Therapy

1/2016	Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
9/2009	Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.
5/2007	Prophylactic cranial irradiation for patients with lung cancer.
12/2005	Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy.
5/2005	Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.
5/2003	Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurie E Gaspar Research Topics

Disease

36	Brain Neoplasms (Brain Tumor) 10/2022 - 01/2004
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2003
28	Neoplasms (Cancer) 10/2022 - 02/2002
15	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2004
14	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2005
12	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022 - 01/2004
11	Disease Progression 12/2016 - 05/2005
8	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 11/2011
6	Glioma (Gliomas) 11/2014 - 04/2004
4	Neutropenia 11/2006 - 05/2003
3	Radiation Pneumonitis 01/2022 - 09/2011
3	Pneumonia (Pneumonitis) 01/2022 - 05/2003
3	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2017
3	Neurologic Manifestations (Neurological Manifestations) 01/2019 - 01/2010
3	Necrosis 03/2015 - 04/2009
3	Esophagitis 11/2006 - 08/2004
2	Adenocarcinoma of Lung 01/2022 - 10/2016
2	Melanoma (Melanoma, Malignant) 10/2018 - 01/2010
2	Weight Loss (Weight Reduction) 01/2008 - 11/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020
1	Death (Near-Death Experience) 09/2019
1	Thymoma (Thymic Carcinoma) 01/2017
1	Margins of Excision 01/2017
1	Adenocarcinoma 10/2016
1	Hemoptysis 09/2015
1	Residual Neoplasm 03/2015
1	Oligodendroglioma 11/2014
1	Astrocytoma (Pilocytic Astrocytoma) 11/2014
1	Thoracic Diseases 01/2013
1	Optic Nerve Diseases (Optic Neuropathy) 01/2011
1	Edema (Dropsy) 01/2010
1	Brain Diseases (Brain Disorder) 01/2010
1	Ependymoma 07/2009
1	Hypoxia (Hypoxemia) 06/2009
1	Vascular System Injuries 04/2009
1	Craniopharyngioma (Craniopharyngiomas) 02/2009
1	Diarrhea 03/2008
1	Dermatitis 03/2008
1	Vomiting 08/2004
1	Febrile Neutropenia 08/2004
1	Esophageal Neoplasms (Esophageal Cancer) 04/2004

Drug/Important Bio-Agent (IBA)

9	Temozolomide (Temodar)FDA LinkGeneric 01/2016 - 01/2010
7	Cisplatin (Platino)FDA LinkGeneric 09/2015 - 01/2004
5	Docetaxel (Taxotere)FDA Link 09/2015 - 05/2003
5	Etoposide (VP 16)FDA LinkGeneric 09/2015 - 01/2004
3	Anaplastic Lymphoma KinaseIBA 01/2022 - 03/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2009
3	SteroidsIBA 01/2019 - 01/2010
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2010
3	Bevacizumab (Avastin)FDA Link 09/2015 - 03/2015
3	Gefitinib (Iressa)FDA Link 04/2009 - 03/2008
2	Memantine (Namenda)FDA Link 10/2022 - 01/2019
2	B7-H1 AntigenIBA 01/2022 - 10/2020
2	hydroxide ionIBA 01/2021 - 10/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2017
2	Estrogen ReceptorsIBA 01/2020 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 01/2019
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 12/2012
2	CrizotinibIBA 03/2014 - 12/2012
2	motexafin gadoliniumIBA 11/2011 - 01/2004
2	Tirapazamine (SR 4233)IBA 06/2009 - 08/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2006 - 01/2004
1	pembrolizumabIBA 10/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	Hormones (Hormone)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 10/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2016
1	Phenobarbital (Luminal)FDA Link 05/2013
1	Cetuximab (Erbitux)FDA Link 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Tyrosine Kinase InhibitorsIBA 12/2012
1	vandetanib (ZD6474)IBA 01/2012
1	Biological ProductsIBA 11/2011
1	fotemustine (Muphoran)IBA 01/2010
1	Biomarkers (Surrogate Marker)IBA 09/2009
1	AlbuminsIBA 11/2006

Therapy/Procedure

60	Radiotherapy 10/2022 - 01/2004
32	Therapeutics 10/2022 - 02/2002
20	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
9	Chemoradiotherapy 09/2015 - 05/2003
6	Cranial Irradiation 06/2019 - 05/2007
6	Combined Modality Therapy 01/2016 - 05/2003
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2015 - 01/2009
3	Retreatment 01/2018 - 01/2010
3	Re-Irradiation 01/2018 - 07/2009
2	Adjuvant Chemotherapy 09/2017 - 12/2007
2	Induction Chemotherapy 01/2013 - 09/2011
2	Aftercare (After-Treatment) 01/2011 - 05/2005
1	Combination Drug Therapy (Combination Chemotherapy) 03/2016
1	Brachytherapy 11/2013
1	Palliative Care (Palliative Therapy) 07/2012
1	Investigational Therapies (Experimental Therapy) 01/2010
1	Molecular Targeted Therapy 09/2009
1	Image-Guided Radiotherapy 09/2009
1	Conformal Radiotherapy 01/2009
1	Liver Transplantation 12/2005
1	Hepatectomy 12/2005